학술논문

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients.
Document Type
Article
Source
Melanoma Research; Apr2017, Vol. 27 Issue 2, p110-115, 6p, 3 Charts, 3 Graphs
Subject
Language
ISSN
09608931